Account
Publications
15.10.2024
WODC Europe 2024: Are NICE Achieving Their Timelin...

AUTHORS: Amrit Kaliasethi, Tia Kwong, Mariam Bibi OBJECTIVES  In 2013, England’s National Ins...

Read more
Insider Insights
05.09.2024
NICE’s 1000th Appraisal: Iptacopan for Paroxysma...

The recent appraisal by the National Institute for Health and Care Excellence (NICE) for Iptacopan, ...

Read more
Publications
22.08.2024
ISPOR Europe 2024: Can Patient Involvement Help Op...

We explore whether including the patient voice in early stages of drug development optimises patient...

Read more
Insider Insights
16.08.2024
Health Technology Evaluation

Key findings from the ABPI's latest report highlight challenges and opportunities in NICE's health t...

Read more
Articles
15.08.2024
The role of Health Technology Assessments (HTA) in...

As the focus on sustainability grows, manufacturers will need to address their products’ environme...

Read more
Insider Insights
12.06.2024
Scotland leads the UK in approving Mounjaro for ob...

Scottish Medicines Consortium approves the use of obesity treatment under the NHS in UK first, whils...

Read more
Insider Insights
30.05.2024
NICE and NHS England unveil plan to facilitate qui...

NHS and NICE propose faster adoption of MedTech, streamlining funding and market access for innovati...

Read more
Insider Insights
01.05.2024
Ground-breaking decision: first medicine ever with...

NHS takes a bold step towards achieving net zero by decommissioning desflurane due to its high globa...

Read more
Articles
05.03.2024
VPAG for manufacturers: boom or gloom for UK launc...

We discuss the 2024 VPAG agreement, how it differs from the previous VPAS and whether this will impa...

Read more
Webinar
28.02.2024
VPAS is dead, long live VPAG: the impact of the UK...

Webinar: Discussions on the new Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.